New oral Covid-19 drug in India: 'Faster recovery, less oxygen dependency'
BS Web Team Last Updated at May 9, 2021 18:26 IST
New oral Covid-19 drug in India: 'Faster recovery, less oxygen dependency'
An anti-COVID oral drug developed by the DRDO has been approved by the Drugs Controller General of India (DCGI) for emergency use as an adjunct therapy in moderate to severe coronavirus patients. Clinical trials of the drug 2-deoxy-D-glucose (2-DG) showed that it helps in faster recovery of hospitalised patients and reduces supplemental oxygen dependence.
Watch the video to know more.
POPULAR VIDEOS
MORE VIDEOS
-
JULY 01, 2022, FRIDAY
List of single-use plastics items now banned in India
Single-use plastic is now banned in India, starting 1st July. People ...
-
JULY 01, 2022, FRIDAY
5 years of GST: Changes in tax rates
The Goods and Service Tax regime is now five years old in India. Over ...
-
JULY 01, 2022, FRIDAY
TDS on crypto, Aadhaar-PAN: 5 changes that will come into effect from ...
TDS on crypto, Aadhaar-PAN linking penalty: Take a look at 5 changes ...
-
JULY 01, 2022, FRIDAY
5 years of GST: Hits, misses and the road ahead for India's tax
The Goods and Service Tax regime is now five years old in India. Over ...
-
JUNE 29, 2022, WEDNESDAY
From compensation to rates, highlights from GST council's 2-day ...
The two-day meeting of the GST Council concluded on June 29 without ...
-
ADVERTISEMENT
